| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_39c68430bcb778feae2ad4e9640ad0ca |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-312
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3233 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-765 |
| filingDate |
2002-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5073ee35383c85dcba1381809ee2b7e9 |
| publicationDate |
2002-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-02092617-A1 |
| titleOfInvention |
Combined approach to treatment of cancer using a c-myc antisense oligomer |
| abstract |
Improved therapeutic methods for treatment of cancer by a combination treatment regimen that includes an oligomer to c-myc and a standard chemotherapeutic agent are provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10344281-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3000480-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10023867-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10017763-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10760078-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007064945-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11020417-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10752900-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11208655-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9278987-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007064945-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007065017-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9469664-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8815599-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007065017-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010505741-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013124807-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9393258-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9249243-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8367628-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11072793-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10202602-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2648140-C2 |
| priorityDate |
2001-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |